Endocrinology & Metabolism Clinical Trials

Statistical methods in endocrinology & metabolism trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All endocrinology & metabolism trials

1,009 results

• CHOOSEIndependent statistical analysis of Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 120NCT01112865
• Chronic Liver Disease in Urea Cycle Disorders: Complete Statistical AnalysisIndependent statistical analysis of Chronic Liver Disease in Urea Cycle Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03721367).Phase NAResults postedn = 28NCT03721367
• Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01483118).Phase 3Results postedn = 45NCT01483118
• CIRTIndependent statistical analysis of Cardiovascular Inflammation Reduction Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01594333).Phase 3Results postedn = 4,786NCT01594333
• Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 45NCT00083122
• CL01-TIndependent statistical analysis of A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously: primary endpoint results, effect…Phase 1/2Results postedn = 3NCT02618512
• CLEAR 2Independent statistical analysis of Combining Lesinurad With Allopurinol in Inadequate Responders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493531).Phase 3Results postedn = 610NCT01493531
• Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04245709).Phase 2Results postedn = 25NCT04245709
• Clinical Assessment of a Closed-loop Insulin Delivery System: Complete Statistical AnalysisIndependent statistical analysis of Clinical Assessment of a Closed-loop Insulin Delivery System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01534013).Phase NAResults postedn = 23NCT01534013
• Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals: Complete Statistical AnalysisIndependent statistical analysis of Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 24NCT02397265
• Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China: Complete Statistical AnalysisIndependent statistical analysis of Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China: primary endpoint results, effect estimate…Phase NAResults postedn = 1,537NCT03064841
• Clinical Evaluation of Effects of an Investigational Tampon on Vaginal Microflora: Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of Effects of an Investigational Tampon on Vaginal Microflora: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 482NCT00913523
• Clinical Study to Compare Two Skin Substitute Categories for Their Effectiveness to Treat Diabetic Foot Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study to Compare Two Skin Substitute Categories for Their Effectiveness to Treat Diabetic Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 24NCT06557122
• Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 4Results postedn = 190NCT01868646
• Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 18NCT01186250
• Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 50NCT04088097
• Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2/3Results postedn = 36NCT00227617
• Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 60NCT00470366
• COMBINE 1Complete statistical analysis of COMBINE 1, a randomized phase 3 trial comparing weekly IcoSema with weekly insulin icodec for glycemic control in people with type 2 diabetes, including the primary HbA1c analysis,…Phase 3Results postedn = 1,291NCT05352815
• Combined Letrozole and Clomid in Women With Infertility and PCOS: Complete Statistical AnalysisIndependent statistical analysis of Combined Letrozole and Clomid in Women With Infertility and PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02802865).Phase 4Results postedn = 70NCT02802865
• Combined Vaginal Misoprostol and Perivascular Vasopressin: Complete Statistical AnalysisIndependent statistical analysis of Combined Vaginal Misoprostol and Perivascular Vasopressin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03815344).Phase 4Results postedn = 74NCT03815344
• COMP-SRIndependent statistical analysis of Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 27NCT02122666
• Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle: Complete Statistical AnalysisIndependent statistical analysis of Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle: primary endpoint results, effect estimate with confidence interval,…Phase NAResults postedn = 55NCT03878745
• Comparing a Novel Phototherapy Kiosk to Oral Vitamin D Supplementation: Complete Statistical AnalysisIndependent statistical analysis of Comparing a Novel Phototherapy Kiosk to Oral Vitamin D Supplementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04556136).Phase NAResults postedn = 106NCT04556136
• Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan: Complete Statistical AnalysisIndependent statistical analysis of Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan:…Phase 3Results postedn = 263NCT02648217
• Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin: Complete Statistical AnalysisIndependent statistical analysis of Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin: primary…Phase 4Results postedn = 437NCT02582242
• Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.: Complete Statistical AnalysisIndependent statistical analysis of Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 47NCT00186537
• Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients: Complete Statistical AnalysisIndependent statistical analysis of Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 12NCT03067480
• Comparison of a Novel 22-gauge Core Biopsy Needle: Complete Statistical AnalysisIndependent statistical analysis of Comparison of a Novel 22-gauge Core Biopsy Needle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01598194).Phase NAResults postedn = 60NCT01598194
• Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with…Phase 4Results postedn = 480NCT00469092
• Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE – Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 422NCT00781937
• Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 13NCT04533646
• Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 339NCT00560417
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 2Results postedn = 245NCT00611884
• Comprehensive Add on Study in Japan: Complete Statistical AnalysisIndependent statistical analysis of Comprehensive Add on Study in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01204294).Phase 3Results postedn = 574NCT01204294
• Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 1,369NCT01814787
• CONCLUDEComplete statistical analysis of the CONCLUDE phase 3 trial comparing insulin degludec 200 units and insulin glargine 300 units/mL in people with inadequately treated type 2 diabetes. Includes the primary hypoglycaemia endpoint,…Phase 3Results postedn = 1,609NCT03078478
• Connected Healthcare for Individuals Living at Home With Chronic Conditions: Complete Statistical AnalysisIndependent statistical analysis of Connected Healthcare for Individuals Living at Home With Chronic Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04339296).Phase NAResults postedn = 91NCT04339296
• CONSERVAIndependent statistical analysis of Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 3NCT05368402
• Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320069).Phase NAResults postedn = 25NCT04320069
• Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 76NCT00694473
• Continuous Glucose Sensor Profiles in Non-Diabetic Subjects: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Sensor Profiles in Non-Diabetic Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717977).Phase 4Results postedn = 74NCT00717977
• Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): Complete Statistical AnalysisIndependent statistical analysis of Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 34NCT05422053
• COPDIndependent statistical analysis of COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 34NCT02251496
• Copper Histidine Therapy for Menkes Diseases: Complete Statistical AnalysisIndependent statistical analysis of Copper Histidine Therapy for Menkes Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001262).Phase 1/2Results postedn = 60NCT00001262
• Corneal Nerves Function and Structure: Complete Statistical AnalysisIndependent statistical analysis of Corneal Nerves Function and Structure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04222660).Phase NAResults postedn = 44NCT04222660
• Cortisol Response to Moderate and Deep Sedation in Children: Complete Statistical AnalysisIndependent statistical analysis of Cortisol Response to Moderate and Deep Sedation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265966).Phase NAResults postedn = 149NCT01265966
• CPEX-011Independent statistical analysis of Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 94NCT00850096
• CREST-2Independent statistical analysis of CREST-2, a randomized trial of carotid revascularization and intensive medical management for asymptomatic carotid stenosis, including its design, primary endpoint, planned statistical analysis, and interpretation.Phase NAn = 2,486NCT02089217
• CTRADIndependent statistical analysis of Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 193NCT01564485

← All therapeutic areas